Effects of insulin-sensitising agents in mice with hepatic insulin resistance

Diabetologia

Volumn 47, Issue 3, 2004, Pages 407-411

  Cohen, S E ^a   Tseng, Y H ^a   Michael, M D ^a   Kahn, C R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus; Metformin; Rosiglitazone; Thiazolidinedione

Indexed keywords

METFORMIN; PLACEBO; ROSIGLITAZONE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC OBESITY; DRUG EFFECT; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOOD GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPIDS; LIVER; METFORMIN; MICE; MICE, KNOCKOUT; MICE, OBESE; RECEPTOR, INSULIN; THIAZOLIDINEDIONES;

EID: 1842833570     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1320-4     Document Type: Article

References (10)

1. Kahn CR, Chen L, Cohen SE (2000) Unraveling the mechanism of action of thiazolidinediones J Clin Invest 106:1305-1307
2. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI (1988) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867-872
3. Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor [published erratum appears in Cell (1995) Mar 24; 80: following 957]. Cell 79:1147-1156
4. Zhou G, Myers R, Li Y et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174
5. Michael MD, Kulkarni RN, Postic C et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97
6. Bruning JC, Michael MD, Winnay JN et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569
7. Halaas JL, Gajiwala KS, Maffei M et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
8. Vestergaard H, Lund S, Pedersen O (2001) Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism. J Intern Med 250:406-414
9. Chao L, Marcus-Samuels B, Mason MM (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106:1221-1228
10. Tseng YH, Ueki K, Kriauciunas KM, Kahn CR (2002) Differential roles of insulin receptor substrates in the antiapoptotic function of insulin-like growth factor-1 and insulin. J Biol Chem 277:31601-31611